Heparin administered to Anopheles in membrane feeding assays blocks Plasmodium development in the mosquito

Elena Lantero, Jessica Fernandes, Carlos Raúl Aláez-Versón, Joana Gomes, Henrique Silveira, Fatima Nogueira, Xavier Fernàndez-Busquets

Research output: Contribution to journalArticle

Abstract

Innovative antimalarial strategies are urgently needed given the alarming evolution of resistance to every single drug developed against Plasmodium parasites. The sulfated glycosaminoglycan heparin has been delivered in membrane feeding assays together with Plasmodium berghei-infected blood to Anopheles stephensi mosquitoes. The transition between ookinete and oocyst pathogen stages in the mosquito has been studied in vivo through oocyst counting in dissected insect midguts, whereas ookinete interactions with heparin have been followed ex vivo by flow cytometry. Heparin interferes with the parasite’s ookinete–oocyst transition by binding ookinetes, but it does not affect fertilization. Hypersulfated heparin is a more efficient blocker of ookinete development than native heparin, significantly reducing the number of oocysts per midgut when offered to mosquitoes at 5 µg/mL in membrane feeding assays. Direct delivery of heparin to mosquitoes might represent a new antimalarial strategy of rapid implementation, since it would not require clinical trials for its immediate deployment.

Original languageEnglish
Pages (from-to)1136-1147
Number of pages11
JournalBiomolecules
Volume10
Issue number8
DOIs
Publication statusPublished - 1 Aug 2020

Keywords

  • Anopheles
  • Antimalarial drugs
  • Heparin
  • Malaria
  • Mosquito
  • Ookinete
  • Plasmodium
  • Transmission blocking

UN Sustainable Development Goals (SDGs)

  • SDG 3 - Good Health and Well-Being

Fingerprint Dive into the research topics of 'Heparin administered to Anopheles in membrane feeding assays blocks Plasmodium development in the mosquito'. Together they form a unique fingerprint.

Cite this